A Summary on Tuberculosis Vaccine Development-Where to Go?
Mycobacterium tuberculosis
bibliometric analysis
immunity
tuberculosis
vaccine
Journal
Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269
Informations de publication
Date de publication:
24 Feb 2023
24 Feb 2023
Historique:
received:
13
01
2023
revised:
23
02
2023
accepted:
23
02
2023
medline:
30
3
2023
entrez:
29
3
2023
pubmed:
30
3
2023
Statut:
epublish
Résumé
Tuberculosis (TB) is an old infectious disease caused by The Science Citation Index Expanded (SCI-E) of the Web of Science Core Collection (WOSCC) database was selected to search the literature related to TB vaccines. The countries, institutions, authors, journals, references, and keywords of each publication were analyzed and visualized using the VOSviewer, CiteSpace, and Bibliometrix software. Furthermore, GraphPad Prism and Microsoft Excel 365 were also used for statistical analysis. As of 20 October 2022, 7960 publications related to TB vaccines were identified with 288,478 citations. The United States of America (USA) accounted for the largest share (2658, 33.40%), followed by the United Kingdom (UK, 1301, 16.34%), and China (685, 8.6%). Regarding affiliations, the University of London had the most publications (427) and shared the highest H-index (76) with the Statens Serum Institut of Denmark. In terms of the number of articles for the journals and authors, the journal Vaccine ranked first with 629 articles. Professor Peter Anderssen has published the highest number of papers (160). The burst keywords and thematic maps analysis showed that future trends in TB vaccine development would focus on exploring the interaction mechanisms between The number of publications on TB vaccines has grown over the past two decades. Developed countries play a significant role in TB vaccine research, and developing countries are fast catching up. We believe that future research will be aimed at understanding the fine molecular mechanisms of host-pathogen interaction, leading to the development of better TB vaccines.
Sections du résumé
BACKGROUND
BACKGROUND
Tuberculosis (TB) is an old infectious disease caused by
METHODS
METHODS
The Science Citation Index Expanded (SCI-E) of the Web of Science Core Collection (WOSCC) database was selected to search the literature related to TB vaccines. The countries, institutions, authors, journals, references, and keywords of each publication were analyzed and visualized using the VOSviewer, CiteSpace, and Bibliometrix software. Furthermore, GraphPad Prism and Microsoft Excel 365 were also used for statistical analysis.
RESULTS
RESULTS
As of 20 October 2022, 7960 publications related to TB vaccines were identified with 288,478 citations. The United States of America (USA) accounted for the largest share (2658, 33.40%), followed by the United Kingdom (UK, 1301, 16.34%), and China (685, 8.6%). Regarding affiliations, the University of London had the most publications (427) and shared the highest H-index (76) with the Statens Serum Institut of Denmark. In terms of the number of articles for the journals and authors, the journal Vaccine ranked first with 629 articles. Professor Peter Anderssen has published the highest number of papers (160). The burst keywords and thematic maps analysis showed that future trends in TB vaccine development would focus on exploring the interaction mechanisms between
CONCLUSION
CONCLUSIONS
The number of publications on TB vaccines has grown over the past two decades. Developed countries play a significant role in TB vaccine research, and developing countries are fast catching up. We believe that future research will be aimed at understanding the fine molecular mechanisms of host-pathogen interaction, leading to the development of better TB vaccines.
Identifiants
pubmed: 36983589
pii: jpm13030408
doi: 10.3390/jpm13030408
pmc: PMC10054751
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Beijing Municipal Science & Technology Commission
ID : L192065
Organisme : Chinese PLA General Hospital
ID : QNC19047
Références
Nature. 2010 Aug 19;466(7309):973-7
pubmed: 20725040
Nat Rev Immunol. 2008 Apr;8(4):247-58
pubmed: 18323851
Nature. 2020 Jan;577(7788):95-102
pubmed: 31894150
Lancet. 2006 Apr 8;367(9517):1173-80
pubmed: 16616560
J Surg Res. 2022 Sep;277:335-341
pubmed: 35561649
JAMA. 1994 Mar 2;271(9):698-702
pubmed: 8309034
Indian J Tuberc. 2022 Oct;69(4):482-495
pubmed: 36460380
Lancet. 2013 Mar 23;381(9871):1021-8
pubmed: 23391465
BMJ Glob Health. 2022 Oct;7(10):
pubmed: 36220305
Cell Res. 2018 Apr;28(4):491-493
pubmed: 29531313
Anaesthesia. 2011 Oct;66(10):873-8
pubmed: 21864299
J Chin Med Assoc. 2022 Mar 1;85(3):401-408
pubmed: 34698695
J Surg Res. 2022 Apr;272:125-131
pubmed: 34968785
Annu Rev Immunol. 2000;18:927-74
pubmed: 10837079
AMIA Annu Symp Proc. 2005;:724-8
pubmed: 16779135
Hum Vaccin Immunother. 2018 Jul 3;14(7):1697-1716
pubmed: 29601253
Tuberculosis (Edinb). 2005 Jan-Mar;85(1-2):29-38
pubmed: 15687025
Tuberculosis (Edinb). 2015 Dec;95(6):713-721
pubmed: 26277695
PLoS One. 2019 Jan 25;14(1):e0210994
pubmed: 30682100
Cell Host Microbe. 2018 Jan 10;23(1):89-100.e5
pubmed: 29324233
Proc Natl Acad Sci U S A. 2011 Nov 22;108(47):18910-4
pubmed: 22065777
PLoS One. 2013 Jun 20;8(6):e66449
pubmed: 23840471
PLoS One. 2012;7(8):e41618
pubmed: 22879892
Science. 2018 Jan 12;359(6372):
pubmed: 29326244
Cells. 2023 Jan 14;12(2):
pubmed: 36672252
Orphanet J Rare Dis. 2022 Jul 29;17(1):297
pubmed: 35906666
BMJ Glob Health. 2021 May;6(5):
pubmed: 34031135
Science. 1999 May 28;284(5419):1520-3
pubmed: 10348738
Science. 2014 Jun 27;344(6191):1492-6
pubmed: 24970081
Infect Immun. 1994 Jun;62(6):2536-44
pubmed: 7910595
Cureus. 2022 Jun 23;14(6):e26268
pubmed: 35911345
Clin Infect Dis. 2014 Feb;58(4):470-80
pubmed: 24336911
N Engl J Med. 2000 Jun 22;342(25):1887-92
pubmed: 10861325
Am J Public Health. 1995 Sep;85(9):1212-7
pubmed: 7661227
Oncology (Williston Park). 2022 Feb 8;36(2):84-91
pubmed: 35180340
Arthritis Care Res (Hoboken). 2016 Jan;68(1):1-25
pubmed: 26545825
N Engl J Med. 2019 Dec 19;381(25):2429-2439
pubmed: 31661198
Nat Commun. 2018 May 15;9(1):1911
pubmed: 29765029
Nature. 1998 Jun 11;393(6685):537-44
pubmed: 9634230
N Engl J Med. 2018 Jul 12;379(2):138-149
pubmed: 29996082
Mol Cell. 2018 Nov 1;72(3):404-412
pubmed: 30388409
Annu Rev Immunol. 2001;19:93-129
pubmed: 11244032
Cell. 2018 Jan 11;172(1-2):176-190.e19
pubmed: 29328912
Front Immunol. 2022 Jul 08;13:953228
pubmed: 35898508
J Clin Invest. 2019 Sep 3;129(9):3482-3491
pubmed: 31478909
Expert Opin Biol Ther. 2020 Jun;20(6):565-578
pubmed: 32149547
Lancet. 1995 Nov 18;346(8986):1339-45
pubmed: 7475776
Front Immunol. 2022 Sep 29;13:998217
pubmed: 36248874
Lancet. 2017 Aug 26;390(10097):849-860
pubmed: 28712537
Nat Med. 2007 Jul;13(7):843-50
pubmed: 17558415
Tomography. 2022 May 01;8(3):1241-1243
pubmed: 35645388
Int Immunopharmacol. 2022 Jul;108:108870
pubmed: 35597119
Arch Environ Occup Health. 2009;64 Suppl 1:8-17
pubmed: 20007113
Pediatrics. 1995 Jul;96(1 Pt 1):29-35
pubmed: 7596718
Nat Rev Microbiol. 2005 Aug;3(8):656-62
pubmed: 16012514
Front Biosci (Landmark Ed). 2022 May 13;27(5):157
pubmed: 35638424
Ophthalmology. 2021 Oct;128(10):1460-1468
pubmed: 33798654
Drug Des Devel Ther. 2020 Sep 24;14:3899-3913
pubmed: 33061296
Proc Natl Acad Sci U S A. 2012 Oct 23;109(43):17537-42
pubmed: 22988082
Front Immunol. 2021 Apr 26;12:666290
pubmed: 33981313
N Engl J Med. 2018 Oct 25;379(17):1621-1634
pubmed: 30280651
Syst Rev. 2018 Sep 27;7(1):147
pubmed: 30261915
Stat Med. 2002 Feb 28;21(4):589-624
pubmed: 11836738
J Telemed Telecare. 2004;10(2):72-7
pubmed: 15068641
Nat Med. 2011 Feb;17(2):189-94
pubmed: 21258338
World Neurosurg. 2022 Nov;167:44-54
pubmed: 36055620
PeerJ. 2013 Oct 22;1:e183
pubmed: 24167778